Delivery Order SPE2DP25D0002-SPE2DP26F0432
- Not listed
- Valneva USA, Inc. (doing business as Intercell USA Inc.) was awarded a $710,457 firm fixed-price delivery order by the Department of Veterans Affairs, Veterans Integrated Service Network 12, on November 1, 2025, for the supply of Japanese Encephalitis Virus Vaccine IXIARO. The contract is scheduled for completion by September 30, 2026, with performance taking place in Bethesda, Maryland. This delivery order was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and...
- This is a $16,016,000.00 firm fixed price delivery order awarded by the Defense Logistics Agency Troop Support Medical to Valneva USA, Inc. (doing business as Intercell USA Inc.), a subsidiary of the French specialty vaccine company Valneva SE. The contract is for the supply of the Japanese encephalitis vaccine IXIARO. This delivery order is part of a larger $48,025,600 indefinite delivery contract awarded to Valneva USA in September 2023, which supports the Department of Defense's medical...
- This is a firm fixed-price delivery order contract awarded to Valneva USA, Inc., a subsidiary of the French vaccine company Valneva SE, by the Medical Supply Chain division of the U.S. Department of Defense. The $5,883,494.40 contract is for the provision of the Japanese encephalitis vaccine IXIARO, with a period of performance ending on July 31, 2025. Valneva USA, Inc. serves as the prime contractor and is responsible for vaccine production and delivery, primarily from its Potomac, Maryland...
- The Department of Veterans Affairs, Veterans Integrated Service Network 12, awarded a delivery order valued at $769,125.84 to Valneva USA, Inc. (doing business as Intercell USA Inc.) on October 1, 2024, for the supply of Japanese encephalitis virus vaccine (IXIARO). This firm fixed-price delivery order is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and carries an ultimate completion date of September 30, 2025. The contract includes no set-aside designation....
- This is a firm fixed-price delivery order contract awarded to Valneva USA, Inc., a foreign-owned, for-profit organization based in Bethesda, Maryland. The contract, valued at $5,883,494.40, is for the delivery of the Japanese encephalitis vaccine IXIARO to support the Medical Supply Chain, a Defense agency. The contract does not have a set-aside designation and is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). Valneva USA, Inc. is the prime contractor responsible...
- Valneva USA, Inc., doing business as Intercell USA Inc., was awarded a $5.8 million firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to provide Japanese encephalitis vaccine. As the prime contractor, Valneva will deliver the vaccine to support the Department of Defense's medical countermeasures program. The contract has a period of performance from June to October 2021, with work taking place in Potomac, Maryland. Valneva's parent company, Valneva SE, is a...
- Valneva USA, Inc. dba Intercell USA, a subsidiary of Valneva, was awarded a $14.4 million firm fixed price delivery order contract by the Defense Logistics Agency Troop Support Medical to provide 8508673583 Japanese encephalitis vaccines. The vaccines will be delivered from Valneva's Potomac, Maryland facility over a four month period concluding in early March 2022. No set aside provisions or subcontractors were identified. This award draws from DLA's prime vendor indefinite...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Valneva USA, Inc. (a subsidiary of the French vaccine company Valneva SE) to supply the Japanese encephalitis vaccine IXIARO. The contract has a ceiling value of $48,000.00 and a completion date of December 31, 2025. It is part of a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $48,025,600, to support the Department of Defense's medical countermeasures...
- This federal contract award, valued at $10,638,400.00, was issued by the Defense Logistics Agency Troop Support Medical to Valneva USA, Inc. (doing business as Intercell USA Inc.), a specialty vaccine company, for the supply of the Japanese encephalitis vaccine IXIARO. The contract is a firm fixed price delivery order with a period of performance through September 30, 2024. Valneva USA, a subsidiary of the France-based Valneva SE, is the prime contractor and holds several other significant...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $14,201,021.80 firm-fixed-price delivery order contract to Valneva USA, Inc. (doing business as Intercell USA Inc.), a subsidiary of the French specialty vaccine company Valneva SE. The contract is for the delivery of the Japanese encephalitis vaccine IXIARO to support the Department of Defense's medical countermeasures program. This delivery order is part of two larger Indefinite Delivery Contracts (IDCs) awarded to Valneva...
- SPE2DP25D0002Indefinite Delivery Contract
- SPE2DP25D0002-SPE2DP26F0432Delivery Order
Valneva USA, Inc., a specialty vaccine manufacturer headquartered in Bethesda, Maryland and subsidiary of French-based Valneva SE, was awarded a delivery order valued at $8.25 million on October 23, 2025, for Japanese encephalitis vaccine (IXIARO) to support the Medical Supply Chain program within the Defense Department. This firm fixed-price delivery order, with an ultimate completion date of December 5, 2025, represents performance at Valneva USA's Bethesda facility and carries no set-aside designation. The award falls under one of the company's significant indefinite delivery vehicles established with the Defense Logistics Agency Troop Support Medical, which manages procurement of critical vaccines supporting Department of Defense medical countermeasures initiatives and military readiness requirements. This delivery order reflects Valneva USA's established role as a primary federal vaccine supplier, leveraging existing indefinite delivery contracts that enable efficient procurement of IXIARO on a firm fixed-price basis. The company's extensive experience fulfilling Japanese encephalitis vaccine requirements across multiple federal agencies—including the Defense Logistics Agency, Department of Veterans Affairs, Department of Health and Human Services, and Department of State—demonstrates its capacity to support military personnel, federal employees, and public health initiatives requiring protection against infectious diseases with significant military readiness implications.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.3m | 10/23/25 |